TPG GP A
APLS icon

TPG GP A’s Apellis Pharmaceuticals APLS Stock Holding History

TPG GP A’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50,000
Closed -$2.01M – 83
2026
Q1 		$2.01M Buy
+50,000
New +$1.08M 0.05% 57

Other funds holding APLS

IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

TPG GP A's APLS Position: Q2 2026 in Review

TPG GP A sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 50,000 shares — an estimated $2.01M sold.

TPG GP A first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $2.01M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • TPG GP A reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • TPG GP A sold 50,000 Apellis Pharmaceuticals shares in Q2 2026, an estimated $2.01M.
  • TPG GP A first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • TPG GP A's Apellis Pharmaceuticals position peaked at $2.01M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on TPG GP A's 13F filing for Q2 2026, filed 14 Aug 2026.